With Democrats seen as likely to retake the House, drug makers are quietly making contingency plans to fend off proposals that would squeeze their profits.
ROBERT PEAR, New York Times
Sat, 10/20/2018 - 5:56am
With Democrats seen as likely to retake the House, drug makers are quietly making contingency plans to fend off proposals that would squeeze their profits.